Advanced search
Publication Cover
Emerging Microbes & Infections Volume 9, 2020 - Issue 1
Submit an article Journal homepage
4,657
Views
38
CrossRef citations to date
0
Altmetric
Articles

Excretion of SARS-CoV-2 through faecal specimens

Yong Zhanga NHC key laboratory for Medical Virology, NHC key laboratory for biosafety. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China.ORCID Iconhttps://orcid.org/0000-0002-2692-5437View further author information
ORCID Icon,
Cao Chena NHC key laboratory for Medical Virology, NHC key laboratory for biosafety. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China.View further author information
,
Yang Songa NHC key laboratory for Medical Virology, NHC key laboratory for biosafety. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China.ORCID Iconhttps://orcid.org/0000-0002-7053-3836View further author information
ORCID Icon,
Shuangli Zhua NHC key laboratory for Medical Virology, NHC key laboratory for biosafety. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China.View further author information
,
Dongyan Wanga NHC key laboratory for Medical Virology, NHC key laboratory for biosafety. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China.View further author information
,
Hui Zhangb Gansu Provincial Center for Disease Control and Prevention, Lanzhou City, People’s Republic of ChinaView further author information
,
Guangyue Hanc Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang City, People’s Republic of ChinaView further author information
,
Yuwei Wengd Fujian Provincial Center for Disease Control and Prevention, Fuzhou City, People’s Republic of ChinaView further author information
,
Jun Xue Heilongjiang Provincial Center for Disease Control and Prevention, Harbin City, People’s Republic of ChinaView further author information
,
Jianan Xuf Sichuan Provincial Center for Disease Control and Prevention, Chengdu City, People’s Republic of ChinaView further author information
,
Pengbo Yug ShaanxiProvincial Center for Disease Control and Prevention, Xi'an City, People’s Republic of China.View further author information
,
Weijia Jiangh Guizhou Provincial Center for Disease Control and Prevention, Guiyang City, People’s Republic of ChinaView further author information
,
Xianda Yangi Jilin Provincial Center for Disease Control and Prevention, Changchun City, People’s Republic of ChinaView further author information
,
Zhongkai Langj Chongqing Wanzhou Center for Disease Control and Prevention, Chongqing City, People’s Republic of ChinaView further author information
,
Dongmei Yana NHC key laboratory for Medical Virology, NHC key laboratory for biosafety. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China.View further author information
,
Yanhai Wanga NHC key laboratory for Medical Virology, NHC key laboratory for biosafety. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China.View further author information
,
Jingdong Songa NHC key laboratory for Medical Virology, NHC key laboratory for biosafety. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China.View further author information
,
George Fu Gaoa NHC key laboratory for Medical Virology, NHC key laboratory for biosafety. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China.;k Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Guizhen Wua NHC key laboratory for Medical Virology, NHC key laboratory for biosafety. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China.Correspondence[email protected]
View further author information
&
Wenbo Xua NHC key laboratory for Medical Virology, NHC key laboratory for biosafety. National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China.Correspondence[email protected]
View further author information
 show all
Pages 2501-2508 | Received 17 Jun 2020, Accepted 27 Oct 2020, Published online: 25 Nov 2020

References

  • Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020 Jan;382(13):1199–1207.
  • Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb;395(10223):514–523.
  • Tang B, Wang X, Li Q, et al. Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J Clin Med. 2020 Feb;9(2):462.
  • Yu P, Zhu J, Zhang Z, et al. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis. 2020 Feb;221(11):1757–1761.
  • Liang WN, Liu M, Chen Q, et al. Assessment of impacts of public health interventions on the SARS epidemic in Beijing in terms of the intervals between its symptom onset, hospital admission, and notification. Biomed Environ Sci. 2005 Jun;18(3):153–158.
  • Tong ZD, Tang A, Li KF, et al. Potential presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerg Infect Dis. 2020 May;26(5):1052–1054.
  • Pan X, Chen D, Xia Y, et al. Asymptomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect Dis. 2020 Feb;20(4):410–411.
  • Gu J, Han B, Wang J. COVID-19: gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020 Mar;158(6):1518–1519.
  • Xiao F, Tang M, Zheng X, et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020 Mar;158(6):1831–1833.
  • Cheung KS, Hung IF, Chan PP, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. Gastroenterology. 2020 Apr;159(1):81–95.
  • Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016 Jul;33(7):1870–1874.
  • Hall TA. Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp. 1999;41:95–98.
  • Yeo C, Kaushal S, Yeo D. Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020 Feb;5(4):335–337.
  • Corman VM, Albarrak AM, Omrani AS, et al. Viral shedding and antibody response in 37 patients with middle east respiratory syndrome coronavirus infection. Clin Infect Dis. 2016 Feb;62(4):477–483.
  • Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 Jan;382(10):929–936.
  • Nouri-Vaskeh M, Alizadeh L. Fecal transmission in COVID-19: a potential shedding route. J Med Virol. 2020 Apr. doi:10.1002/jmv.25816.
  • Zhang S, Diao M, Yu W, et al. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the diamond princess cruise ship: a data-driven analysis. Int J Infect Dis. 2020 Feb;93:201–204.
  • Colaneri M, Seminari E, Piralla A, et al. Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy. J Hosp Infect. 2020 Mar;105(3):474–476.
  • Liu Z, Xiao X, Wei X, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020 Feb;92(6):595–601.
  • Yan R, Zhang Y, Li Y, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020 Mar;367(6485):1444–1448.
  • Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020 Aug;182(4):812–827.
  • Zhang Y, Pan Y, Zhao X, et al. Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020. Biosaf Health. 2020 Sep. doi:10.1016/j.bsheal.2020.08.006.
  • Gao GF. For a better world: biosafety strategies to protect global health. Biosaf Health. 2019;1(1):1–3.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.